SAI
BIIB icon

Savvy Advisors Inc’s Biogen BIIB Stock Holding History

Savvy Advisors Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$708K Sell
3,864
-385
-9% -$70.9K 0.02% 546
2025
Q4 		$748K Buy
4,249
+811
+24% +$132K 0.02% 436
2025
Q3 		$482K Buy
3,438
+373
+12% +$50.4K 0.02% 436
2025
Q2 		$385K Buy
+3,065
New +$382K 0.03% 425

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Savvy Advisors Inc's BIIB Position: Q1 2026 in Review

Savvy Advisors Inc reduced its Biogen (BIIB) stake by 9.1% in Q1 2026, selling an estimated $70.9K and leaving 3,864 shares worth $708K. The position accounts for 0.02% of the portfolio, ranked #546.

Savvy Advisors Inc first reported a position in BIIB in Q2 2025 and has held it in 4 quarters since. The position peaked at $748K in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Savvy Advisors Inc held 3,864 shares of Biogen worth $708K as of Q1 2026.
  • Savvy Advisors Inc sold 385 Biogen shares in Q1 2026, an estimated $70.9K.
  • Biogen made up 0.02% of Savvy Advisors Inc's portfolio in Q1 2026, its #546 holding.
  • Savvy Advisors Inc first reported a position in Biogen in Q2 2025 and has held it in 4 quarters since.
  • Savvy Advisors Inc's Biogen position peaked at $748K in Q4 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.